IFS Advisors’s GE HealthCare GEHC Stock Holding History

IFS Advisors’s Portfolio GEHC Stock Details GEHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-12	Closed	-$816	–	149
2023 Q3	$816	Hold	12	–	–	﹤0.01%	124
2023 Q2	$974	Hold	12	–	–	﹤0.01%	123
2023 Q1	$984	Buy	+12	New	+$857	﹤0.01%	98

Other funds holding GEHC

General Electric Evendale, Ohio $308M AUM 40.86% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

IFS Advisors's GEHC Position: Q4 2023 in Review

IFS Advisors sold out of GE HealthCare (GEHC) in Q4 2023, closing a stake of 12 shares — an estimated $816 sold.

IFS Advisors first reported a position in GEHC in Q1 2023 and held it in 3 quarters. The position peaked at $984 in Q1 2023. 1,185 funds tracked by Wall St. Rank hold GEHC as of Q4 2023.

IFS Advisors reported no remaining GE HealthCare position as of Q4 2023 after selling out during the quarter.
IFS Advisors sold 12 GE HealthCare shares in Q4 2023, an estimated $816.
IFS Advisors first reported a position in GE HealthCare in Q1 2023 and held it in 3 quarters.
IFS Advisors's GE HealthCare position peaked at $984 in Q1 2023.
1,185 funds tracked by Wall St. Rank held GE HealthCare as of Q4 2023.

Based on IFS Advisors's 13F filing for Q4 2023, filed 5 Jan 2024.